<DOC>
	<DOCNO>NCT03006588</DOCNO>
	<brief_summary>EUS-FNA RPLN NPC</brief_summary>
	<brief_title>EUS-FNA Retropharyngeal Lymph Node ( RPLN ) Recurrent Nasopharyngeal Carcinoma ( NPC ) Patients</brief_title>
	<detailed_description>To evaluate safety efficacy novel minimally invasive sampling technique -- fine needle aspiration ( FNA ) guide endoscopic ultrasound ( EUS ) , aim sample tissue retropharyngeal lymph node ( RPLN ) diagnosis patient suspect recurrent nasopharyngeal carcinoma ( NPC ) .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>1. undifferentiated , nonkeratinizing carcinoma initial diagnosis ( WHO , 1991 criterion ) evidence distant metastasis obtain radiotherapy ; 2. receive regular chemotherapy cytotoxic agent cisplatin , carboplatin , 5fluorouracil , paclitaxel , etc , coordinate radiotherapy standard dos ( approximate 5070 Gy ) nasopharynx neck respectively . Within 3 month radiotherapy , local distant lesion find ; 3. regular followup , enlarge RPLN detect MRI 6 month later since radiotherapy accomplish ; 4. n't receive chemotherapy radiotherapy , immunotherapy salvage surgery completion radiotherapy suspicious recurrent lesion RPLN detect ; 5. recurrent lesion nasopharynx find white light endoscopy well cancer cell negative pathology bite biopsy ; 6. single lesion RPLN , recurrent metastatic lesion find local region distant organ . 7. minimum axial diameter RPLN 5mm . ( 1 ) patient nasal stenosis ; ( 2 ) patient coagulation dysfunction ; ( 3 ) patient distant metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>FNA , EUS , retropharyngeal lymph node ( RPLN ) , NPC</keyword>
</DOC>